Literature DB >> 28809768

Missed Opportunities for Chlamydia Screening in Title X Family Planning Clinics.

Sarah Goldenkranz Salomon1, Elizabeth Torrone, Wendy Nakatsukasa-Ono, David N Fine.   

Abstract

BACKGROUND: Annual chlamydia (CT) screening is recommended for women younger than 25 years, yet less than half of young women seeking health care are screened annually. We analyzed Title X family planning service data from the Northwest United States to assess factors associated with missed opportunities for CT screening. Our primary hypothesis was screening coverage is higher during annual preventive health visits compared to other visit types. Study objectives were: (1) identify gaps in screening coverage by patient demographics, visit characteristics, and clinic measures; and (2) examine the association between visit type and CT screening by controlling for other covariates and stratifying by state.
METHODS: Calendar year 2011 Title X visit records (n = 180,856) were aggregated to the patient level (n = 112,926) to assess CT screening coverage by all characteristics. Screening variation was explored by bivariate and multivariate Poisson regression. Adjusted models for each state estimated association between comprehensive examination and screening controlling for confounders.
RESULTS: Clinic and visit characteristics were associated with CT screening. Coverage ranged from 45% in Washington to 80% in Alaska. Only 34% of patients visited for a routine comprehensive examination. Visit type was associated with screening; 75% of patients who had a comprehensive examination were screened versus 34% of those without a comprehensive examination (unadjusted PR, 2.18; 95% confidence interval, 2.16-2.21). The association between comprehensive examination and CT screening varied significantly by state (interaction term, P < 0.001).
CONCLUSIONS: Missed screening opportunities are common among women who access brief appointments for specific needs but do not seek routine preventive care, particularly in some states. Structural interventions may help address these systematically missed opportunities.

Entities:  

Mesh:

Year:  2017        PMID: 28809768      PMCID: PMC6893299          DOI: 10.1097/OLQ.0000000000000641

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  19 in total

1.  Chlamydia positivity in women screened in family planning clinics: racial/ethnic differences and trends in the northwest U.S., 1997-2006.

Authors:  David Fine; Katherine K Thomas; Wendy Nakatsukasa-Ono; Jeanne Marrazzo
Journal:  Public Health Rep       Date:  2012 Jan-Feb       Impact factor: 2.792

2.  Comparison of adherence to chlamydia screening guidelines among Title X providers and non-Title X providers in the California Family Planning, Access, Care, and Treatment Program.

Authors:  Joan M Chow; Heike Thiel de Bocanegra; Denis Hulett; Hye-Youn Park; Philip Darney
Journal:  J Womens Health (Larchmt)       Date:  2012-06-13       Impact factor: 2.681

3.  Reduction in unnecessary Chlamydia screening among older women at title X-funded family planning sites following a structural intervention--San Francisco, 2009.

Authors:  Kyle T Bernstein; Julia L Marcus; Ameera Snell; Sally Liska; Leah Rauch; Susan S Philip
Journal:  Sex Transm Dis       Date:  2011-02       Impact factor: 2.830

4.  Chlamydia screening in a Health Plan before and after a national performance measure introduction.

Authors:  Gale R Burstein; Mark H Snyder; Deborah Conley; Daniel R Newman; Cathleen M Walsh; Guoyu Tao; Kathleen L Irwin
Journal:  Obstet Gynecol       Date:  2005-08       Impact factor: 7.661

5.  Sexually transmitted diseases treatment guidelines, 2015.

Authors:  Kimberly A Workowski; Gail A Bolan
Journal:  MMWR Recomm Rep       Date:  2015-06-05

6.  The intersection of progress and missed opportunities: provider group variations in chlamydia screening practices within California's Family Planning, Access, Care, and Treatment Program.

Authors:  Kathleen Tebb
Journal:  J Womens Health (Larchmt)       Date:  2012-08       Impact factor: 2.681

Review 7.  Chlamydia screening for sexually active young women under the Affordable Care Act: new opportunities and lingering barriers.

Authors:  Penny S Loosier; Mary-Beth Malcarney; Lauren Slive; Ryan C Cramer; Brittany Burgess; Karen W Hoover; Raul Romaguera
Journal:  Sex Transm Dis       Date:  2014-09       Impact factor: 2.830

8.  Computer reminders for Chlamydia screening in general practice: a randomized controlled trial.

Authors:  Jennifer Walker; Christopher K Fairley; Sandra M Walker; Lyle C Gurrin; Jane M Gunn; Marie V Pirotta; Rob Carter; Jane S Hocking
Journal:  Sex Transm Dis       Date:  2010-07       Impact factor: 2.830

9.  Use of home-obtained vaginal swabs to facilitate rescreening for Chlamydia trachomatis infections: two randomized controlled trials.

Authors:  Fujie Xu; Bradley P Stoner; Stephanie N Taylor; Leandro Mena; Lin H Tian; John Papp; Kathleen Hutchins; David H Martin; Lauri E Markowitz
Journal:  Obstet Gynecol       Date:  2011-08       Impact factor: 7.661

10.  Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-12-16       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.